Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-13 7:18 pm Purchase | 2025-01-10 | 13D | Zymeworks Inc. ZYME | EcoR1 Capital LLC | 15,411,078 22.400% | 718,797 (+4.89%) | Filing History |
| 2025-01-03 7:45 pm Unchanged | 2024-12-31 | 13D | Prothena Corporation plc PRTA | EcoR1 Capital LLC | 11,584,280 21.500% | 0 (Unchanged) | Filing History |
| 2024-12-23 7:54 pm Purchase | 2024-12-19 | 13D | Zymeworks Inc. ZYME | EcoR1 Capital LLC | 14,692,281 21.300% | 559,990 (+3.96%) | Filing History |
| 2024-12-23 7:50 pm Sale | 2024-12-19 | 13G | Mersana Therapeutics, Inc. MRSN | EcoR1 Capital LLC | 11,578,447 9.990% | -7,786,241 (-40.21%) | Filing History |
| 2024-12-17 5:01 pm Purchase | 2024-12-10 | 13G | uniQure N.V. QURE | EcoR1 Capital LLC | 3,632,087 7.500% | 3,632,087 (New Position) | Filing History |
| 2024-12-09 4:04 pm Purchase | 2024-12-02 | 13G | Eton Pharmaceuticals, Inc. ETON | EcoR1 Capital LLC | 1,397,669 5.400% | 1,397,669 (New Position) | Filing History |
| 2024-11-15 10:34 am Sale | 2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 5,441,896 6.400% | -1,553,965 (-22.21%) | Filing History |
| 2024-11-14 6:22 pm Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | EcoR1 Capital LLC | 1,250,385 1.300% | -2,242,809 (-64.21%) | Filing History |
| 2024-11-14 6:19 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital LLC | 356,117 9.990% | 356,117 (New Position) | Filing History |
| 2024-11-14 6:16 pm Purchase | 2024-09-30 | 13G | Xencor, Inc. XNCR | EcoR1 Capital LLC | 6,719,304 9.400% | 1,436,788 (+27.20%) | Filing History |
| 2024-11-14 6:13 pm Purchase | 2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 5,617,719 9.990% | 1,766,212 (+45.86%) | Filing History |
| 2024-11-14 6:10 pm Purchase | 2024-09-30 | 13G | Atara Biotherapeutics, Inc. ATRA | EcoR1 Capital LLC | 493,463 9.990% | 493,463 (New Position) | Filing History |
| 2024-11-14 6:07 pm Purchase | 2024-09-30 | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital LLC | 571,727 5.900% | 571,727 (New Position) | Filing History |
| 2024-11-14 6:04 pm Sale | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital LLC | 1,608,616 4.400% | -336,056 (-17.28%) | Filing History |
| 2024-11-14 6:01 pm Sale | 2024-09-30 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital LLC | 0 0.000% | -6,117,400 (Position Closed) | Filing History |
| 2024-11-14 5:54 pm Sale | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,418,068 4.900% | -2,857,142 (-45.53%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital LLC | 4,288,120 4.800% | 132,745 (+3.19%) | Filing History |
| 2024-11-14 5:43 pm Sale | 2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital LLC | 3,223,851 2.900% | -2,394,928 (-42.62%) | Filing History |
| 2024-10-08 4:35 pm Purchase | 2024-10-06 | 13D | Galapagos NV GLPG | EcoR1 Capital LLC | 7,094,049 10.770% | 588,159 (+9.04%) | Filing History |
| 2024-09-03 5:51 pm Purchase | 2024-08-23 | 13G | Aadi Bioscience, Inc. AADI | EcoR1 Capital LLC | 1,845,253 7.500% | 1,845,253 (New Position) | Filing History |